Shenzhen Lifotronic Technology Co., Ltd.

SHSE:688389 Stock Report

Market Cap: CN¥5.6b

Shenzhen Lifotronic Technology Past Earnings Performance

Past criteria checks 2/6

Shenzhen Lifotronic Technology has been growing earnings at an average annual rate of 22.7%, while the Medical Equipment industry saw earnings declining at 3.5% annually. Revenues have been growing at an average rate of 18.3% per year. Shenzhen Lifotronic Technology's return on equity is 13.8%, and it has net margins of 27.6%.

Key information

22.7%

Earnings growth rate

22.1%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate18.3%
Return on equity13.8%
Net Margin27.6%
Last Earnings Update31 Mar 2025

Recent past performance updates

Recent updates

Returns Are Gaining Momentum At Shenzhen Lifotronic Technology (SHSE:688389)

Jan 03
Returns Are Gaining Momentum At Shenzhen Lifotronic Technology (SHSE:688389)

Is Shenzhen Lifotronic Technology (SHSE:688389) A Risky Investment?

Oct 24
Is Shenzhen Lifotronic Technology (SHSE:688389) A Risky Investment?

Investors Still Aren't Entirely Convinced By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Earnings Despite 33% Price Jump

Oct 02
Investors Still Aren't Entirely Convinced By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Earnings Despite 33% Price Jump

Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital

Aug 16
Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital

Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?

Jul 25
Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?

Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E

May 24
Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E

Shenzhen Lifotronic Technology (SHSE:688389) Might Have The Makings Of A Multi-Bagger

Apr 17
Shenzhen Lifotronic Technology (SHSE:688389) Might Have The Makings Of A Multi-Bagger

Revenue & Expenses Breakdown

How Shenzhen Lifotronic Technology makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SHSE:688389 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 251,057292230207
31 Dec 241,148345229201
30 Sep 241,193381197187
30 Jun 241,177366214175
31 Mar 241,174348224178
31 Dec 231,146329225173
30 Sep 231,119303263170
30 Jun 231,095286240176
31 Mar 231,051272217171
31 Dec 22983251196171
30 Sep 22907221179177
30 Jun 22869207171177
31 Mar 22824203158162
31 Dec 21778190157156
30 Sep 21705173147148
30 Jun 21651157138132
31 Mar 21596160123112
31 Dec 20554144116103
30 Sep 2051612711897
30 Jun 2047711911188
31 Mar 2045011110681
31 Dec 194231019978
30 Sep 1940010210370
31 Dec 18323818367
31 Dec 17251566650
31 Dec 16175107539

Quality Earnings: 688389 has high quality earnings.

Growing Profit Margin: 688389's current net profit margins (27.6%) are lower than last year (29.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 688389's earnings have grown significantly by 22.7% per year over the past 5 years.

Accelerating Growth: 688389's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 688389 had negative earnings growth (-16.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-2.6%).

Return on Equity

High ROE: 688389's Return on Equity (13.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/08 21:21
End of Day Share Price 2025/05/08 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shenzhen Lifotronic Technology Co., Ltd. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuo SongCitic Securities Co., Ltd.
Zhu ChenCitic Securities Co., Ltd.
Binbin ZhangCitic Securities Co., Ltd.